DW Healthcare Partners (DWHP), a healthcare-focused private equity firm, is pleased to announce an investment in Med-Pharmex, Inc. of Pomona, California. Med-Pharmex offers pharmaceutical research, formulation, and manufacturing in the animal health industry. Med-Pharmex’s veterinary pharmaceuticals include products for companion animals, such as dogs, cats, and horses, and food-producing animals, such as cattle, swine and poultry. The company operates three manufacturing facilities and is committed to the continued development of newer products, and to serving the veterinary community with a complete line of quality generic products at a reasonable cost.
DWHP’s investment in Med-Pharmex, Inc. marks another partnership within the private equity firm’s recently-established third healthcare fund.
Andrew Carragher, Co-founder and Managing Director stated, ‘We are very pleased to have this opportunity to partner with Gerry and his talented team. Med-Pharmex is uniquely positioned within the animal health market. It will provide us with a stable platform that can be further leveraged as new products are added to the portfolio, via internal research and development, product acquisitions, and strategic manufacturing partnerships.’
ABOUT DW HEALTHCARE PARTNERS
DW Healthcare Partners is a private equity firm focused exclusively on the healthcare industry. The firm manages over $800 million in committed capital and invests in profitable healthcare companies with proven management teams.
DW Healthcare Partners is led by seasoned healthcare executives with more than 110 years of combined industry experience. The firm provides the capital, strategic guidance, and acquisition expertise to help mid-to-late-stage companies realize their potential for growth.